<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" version="2.0">
    <channel>
        <title>Molecular Medicine</title>
        <description>Molecular Medicine publishes original research articles and expert commentaries on emerging concepts in the interdisciplinary field of molecular medicine.
Considered the vanguard of the new millennium in which science truly complements the art of medicine, Molecular Medicine strives to understand the molecules key to normal body functioning and the pathogenesis of disease, and based on that knowledge, to design specific molecular tools for diagnosis, treatment and prevention.
A nonprofit journal organized and peer-reviewed by expert scientists and editors, Molecular Medicine is committed to:
• providing a venue where rigor and scholarship reign,
• promoting and advancing scientific discourse, and&lt;br /&gt;
• imparting a common language and understanding among diverse clinical groups, from allergists to virologists and everyone in between.
Like the field, Molecular Medicine the journal continues to grow as it scales the heights of modern biomedical science. It has captured the imagination of many of the best basic science and clinical investigators. Pick up an issue today and see for yourself!</description>
        <link>http://www.molmed.org</link>
        <category>Science &amp; Medicine</category>
        <copyright>2008 Molecular Medicine</copyright>
        <lastBuildDate>Tue, 02 Jun 2009 09:52:09 -0400</lastBuildDate>
        <managingEditor>mpuerta@NSHS.edu</managingEditor>
        <pubDate>Tue, 02 Jun 2009 09:51:44 -0400</pubDate>
        <webMaster>kstroud@optonline.net</webMaster>
        <generator>FeedForAll Mac v2.1 (2.1.0.2); http://www.FeedForAll.com/</generator>
        <image>
            <url>http://www.molmed.org/images/MolMedCover_5_6_09.jpg</url>
            <title>Molecular Medicine</title>
            <link>http://www.molmed.org</link>
            <description>Insight into the Cellular and Molecular Basis of Disease</description>
            <width>110</width>
            <height>140</height>
        </image>
        <item>
            <title>&quot;Mollie Medcast&quot; Episode 48 (Molecular Medicine podcast)</title>
            <description>RA, Myocardial Infarction, and non-Hodgkin Lymphoma</description>
            <link>http://www.molmed.org/mp3s/Episode48.mp3</link>
            <guid isPermaLink="false">2466F574-4F7C-11DE-BD27-0014510BD93E-90521-0000104702057560-FFA</guid>
            <pubDate>Tue, 02 Jun 2009 09:50:11 -0400</pubDate>
        </item>

        <item>
            <title>&quot;Mollie Medcast&quot; Episode 47 (Molecular Medicine podcast)</title>
            <description>Disease Awareness in May</description>
            <link>http://www.molmed.org/mp3s/Episode47.mp3</link>
            <guid isPermaLink="false">4AC46A44-4F7C-11DE-BD27-0014510BD93E-90521-0000104781E64ACE-FFA</guid>
            <pubDate>Tue, 02 Jun 2009 09:51:17 -0400</pubDate>
        </item>

        <item>
            <title>Boning Up On Hyperglycemia</title>
            <description>Bone marrow–derived endothelial progenitor cells (EPC) are critical for maintaining the integrity and health of the vasculature. In diabetes, however, the numbers of these cells in the circulation are reduced, which may lead to ischemic vascular disease in these patients. Loomans et al. demonstrate that hyperglycemia drives the fate of EPC away from forming helpful, proangiogenic cells &lt;br /&gt;
capable of remodeling the endothelium to forming proinflammatory cells instead. Their work helps us appreciate the underlying cause of vascular complications in diabetes patients and may serve to outline a specific use of bone marrow cells in neovascularization therapy.</description>
            <link>http://www.molmed.org/content/2009/5_6_09/152_159.vanZonneveld.00032.PDF</link>
            <guid isPermaLink="false">CD9B8AE6-A9BA-11DD-860A-0014510BD93E-733-0000002C57448DCD-FFA</guid>
            <pubDate>Mon, 27 Apr 2009 10:50:46 -0400</pubDate>
        </item>

        <item>
            <title>Matters Of The Heart</title>
            <description>Congestive heart failure (CHF) can be the final result of a series of events including necrosis of the myocardium, coronary artery occulsion, and myocardial infarction (MI). Until recently it was thought that once cells in this tissue were damaged, there was no possibility for regeneration. Stavropoulou et al. examine the role of IGF expression in myocardium repair following MI in Wistar rats. The authors postulate that the IGF-1 isoforms, IGF-1Ea and MGF-E, each have unique roles to play in myocardial repair processes. This work could ultimately impact clinical options in the immediate aftermath of MI.</description>
            <link>http://www.molmed.org/content/2009/5_6_09/127_135.Koutsilieris.00012.pdf</link>
            <guid isPermaLink="false">6D4B89D4-916C-11DC-909A-0014510BD93E-17496-0000048FE4895858-FFA</guid>
            <pubDate>Mon, 27 Apr 2009 10:49:57 -0400</pubDate>
        </item>

        <item>
            <title>View All Articles in the May-June 2009 Issue of Molecular Medicine</title>
            <description>Vol 15/No 1-2
Published by The Feinstein Institute for Medical Research</description>
            <link>http://www.molmed.org/content/2009/5_6_09.htm</link>
            <guid isPermaLink="false">F4FE4178-B947-11DC-AB6F-0014510BD93E-5990-0000015FEE23FAC9-FFA</guid>
            <pubDate>Mon, 27 Apr 2009 10:38:24 -0400</pubDate>
        </item>

        <item>
            <title>Papers in Press - Read new papers prior to publication.</title>
            <description>GTS-21 Attenuates Cytokine Production In Human Whole Blood And Human Monocytes
TPC: Non-erythropoietic Tissue Protective Compound ... more
 
 </description>
            <link>http://www.molmed.org</link>
            <guid isPermaLink="false">E83EBF4E-8701-11DC-B50B-0014510BD93E-3049-0000012299B8F2DB-FFA</guid>
            <pubDate>Mon, 27 Apr 2009 10:52:39 -0400</pubDate>
        </item>

    </channel>
</rss>
